Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)
Develops and sells cancer drugs, vaccines, medical devices, and diagnostic equipment across China and globally.
23.00+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-16.5%
The outlook
Shanghai Fosun Pharmaceutical is trading near the lower end of its 52-week range, sitting just 18% up from its low, with a mixed price trend against moving averages suggesting no clear directional momentum. Analyst coverage appears thin, and the stock carries a bearish lean overall, though the trailing P/E of 17.6 sits at a moderate valuation level.
What’s behind the score
Price trendMixed vs its moving averages
52-week range18% of the way from its 52-week low to high
Market cap
$61.42B
52-wk high
33.10
52-wk low
20.85
50-day avg
22.92
200-day avg
25.83
Trailing P/E
17.6